Synergy Remedies Profile
Key Indicators
- Authorised Capital ₹ 53.00 Cr
as on 21-09-2024
- Paid Up Capital ₹ 52.49 Cr
as on 21-09-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 48.55 Cr
as on 21-09-2024
- Satisfied Charges ₹ 47.34 Cr
as on 21-09-2024
- Revenue 94.94%
(FY 2023)
- Profit -11.35%
(FY 2023)
- Ebitda 44.05%
(FY 2023)
- Net Worth -11.34%
(FY 2023)
- Total Assets 0.49%
(FY 2023)
About Synergy Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 53.00 Cr and a paid-up capital of Rs 52.49 Cr.
The company currently has active open charges totaling ₹48.55 Cr. The company has closed loans amounting to ₹47.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Synergy Remedies Private Limited India is Raveena Goel as COMPANY SECRETARY. Venkata Seerla, Venkata Seerla, Padmaja Nettem, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC122663
- Company No.
122663
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Synergy Remedies?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkata Seerla | Managing Director | 10-Mar-2011 | Current |
Raveena Goel | Company Secretary | 27-Jul-2022 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkata Seerla | Whole-Time Director | 10-Mar-2011 | Current |
Padmaja Nettem | Whole-Time Director | 23-May-2016 | Current |
Rudrani Nalubolu | Whole-Time Director | 06-Jun-2019 | Current |
Financial Performance of Synergy Remedies.
Synergy Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 94.94% increase. The company also saw a substantial fall in profitability, with a 11.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Synergy Remedies?
In 2022, Synergy Remedies had a promoter holding of 45.90% and a public holding of 54.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 28 Apr 2021 | ₹0.92 M | Open |
Hdfc Bank Limited Creation Date: 27 Feb 2021 | ₹2.45 M | Open |
Hdfc Bank Limited Creation Date: 26 Aug 2019 | ₹48.21 Cr | Open |
How Many Employees Work at Synergy Remedies?
Synergy Remedies has a workforce of 32 employees as of Sep 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synergy Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synergy Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.